Stock RNAC CARTESIAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
28.26 USD +15.02% Intraday chart for Cartesian Therapeutics, Inc. +14.88% +36.64%
May. 24 Mizuho Securities Starts Cartesian Therapeutics With Buy Rating MT
May. 22 Cartesian Gets Regenerative Medicine Advanced Therapy Label for Myasthenia Gravis Drug Candidate MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. RNAC Stock
  4. Revisions Cartesian Therapeutics, Inc.